For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Cadus Technologies, Inc.

USPTO Granted Patents = 16

% Expired Patents = 56.3

Forward Citations = 83

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Joshua Trueheart (11 out of 32 patents)

Jeremy I Paul (9 out of 14 patents)

Christine A Klein (9 out of 14 patents)

4. John P Manfredi (9 out of 20 patents)

5. Dana M Fowlkes (8 out of 30 patents)

6. Andrew J Murphy (5 out of 368 patents)

7. James R Broach (5 out of 7 patents)

8. Andrew J M Murphy (4 out of 4 patents)

9. Jim Broach (3 out of 6 patents)

10. Lambertus J Oehlen (2 out of 2 patents)

11. Jun Xu (2 out of 2 patents)

12. Kirill Ostanin (1 out of 8 patents)

13. Benjamin K Benton (1 out of 1 patent)

14. Meng-Yu Wu (1 out of 1 patent)

15. Mary Cismowski (1 out of 4 patents)

16 patents: Sort by Forward Citations

1. 7611854 - Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor (2009-11-03),

2. 7416881 - Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor (2008-08-26),

3. 7361498 - Yeast cells expressing modified G proteins and methods of use therefor (2008-04-22),

4. 7319009 - Methods and compositions for identifying receptor effectors (2008-01-15),

5. 7273747 - Cell having amplified signal transduction pathway responses and uses therefor (2007-09-25),

6. 7250263 - Methods and compositions for identifying receptor effectors (2007-07-31),

7. 7235648 - Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor (2007-06-26),

8. 7223533 - Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways (2007-05-29),

9. 7122305 - Methods and compositions for identifying receptor effectors (2006-10-17),

10. 7105309 - Yeast cells engineered to produce pheromone system protein surrogates and uses therefor (2006-09-12),

11. 7090991 - System for detection of a functional interaction between a compound and a cellular signal transduction component (2006-08-15),

12. 7081360 - Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties (2006-07-25),

13. 7022513 - Cell based signal generation (2006-04-04),

14. 6864060 - Yeast cells expressing modified G proteins and methods of use therefor (2005-03-08),

15. 6555325 - System for detection of a functional interaction between a compound and a cellular signal transduction component (2003-04-29),

Company Overview

Cadus Technologies, Inc. is a New York-based company specializing in the development of advanced technologies for various sectors, including biotechnology and pharmaceuticals. The organization focuses on innovative solutions that enhance drug discovery and development processes, leveraging cutting-edge research to address complex challenges in the life sciences. With a commitment to scientific excellence, Cadus aims to contribute significantly to the advancement of therapeutic options and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

16 Patents

#477 in New York, NY

#1,161 in New York

#19,935 in US

#37,868 in the World

New York, NY, United States of America

Cadus Technologies, Inc.

Forward Citations = 83

17 inventors:

Joshua Trueheart (11 out of 32 patents)

Jeremy I Paul (9 out of 14 patents)

Christine A Klein (9 out of 14 patents)

4. John P Manfredi (9 out of 20 patents)

5. Dana M Fowlkes (8 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cadus Technologies, Inc.. Retrieved from https://idiyas.com/company/cadus-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…